Centaurus Financial, Inc. Vista Gen Therapeutics, Inc. Transaction History

Centaurus Financial, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$1.67 - $2.76 $16,892 - $27,917	-10,115 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$1.96 - $3.15 $225 - $362	115 Added 1.15%	10,115 $32,000
Q1 2021 Apr 30, 2021	BUY	$1.89 - $2.96 $18,900 - $29,600	10,000 New	10,000 $21,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.